Annual Accounts Payable
$348.00 K
-$347.00 K-49.93%
31 December 2023
Summary:
Titan Pharmaceuticals annual accounts payable is currently $348.00 thousand, with the most recent change of -$347.00 thousand (-49.93%) on 31 December 2023. During the last 3 years, it has fallen by -$447.00 thousand (-56.23%). TTNP annual accounts payable is now -93.20% below its all-time high of $5.12 million, reached on 31 December 2013.TTNP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$356.00 K
-$15.00 K-4.04%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly accounts payable is currently $356.00 thousand, with the most recent change of -$15.00 thousand (-4.04%) on 30 June 2024. Over the past year, it has increased by +$8000.00 (+2.30%). TTNP quarterly accounts payable is now -93.41% below its all-time high of $5.41 million, reached on 30 June 2012.TTNP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.3% |
| 3 y3 years | -56.2% | -55.2% |
| 5 y5 years | -57.3% | -56.3% |
TTNP Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.2% | at low | -56.2% | +2.3% |
| 5 y | 5 years | -77.2% | at low | -79.7% | +2.3% |
| alltime | all time | -93.2% | +3.9% | -93.4% | +78.0% |
Titan Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $356.00 K(-4.0%) |
| Mar 2024 | - | $371.00 K(+6.6%) |
| Dec 2023 | $348.00 K(-49.9%) | $348.00 K(-14.5%) |
| Sept 2023 | - | $407.00 K(-31.8%) |
| June 2023 | - | $597.00 K(+5.3%) |
| Mar 2023 | - | $567.00 K(-18.4%) |
| Dec 2022 | $695.00 K(-12.6%) | $695.00 K(-14.4%) |
| Sept 2022 | - | $812.00 K(+83.3%) |
| June 2022 | - | $443.00 K(-5.3%) |
| Mar 2022 | - | $468.00 K(-41.1%) |
| Dec 2021 | $795.00 K(-36.6%) | $795.00 K(+106.0%) |
| Sept 2021 | - | $386.00 K(-12.1%) |
| June 2021 | - | $439.00 K(-42.8%) |
| Mar 2021 | - | $768.00 K(-38.7%) |
| Dec 2020 | $1.25 M(+53.7%) | $1.25 M(-28.4%) |
| Sept 2020 | - | $1.75 M(+14.5%) |
| June 2020 | - | $1.53 M(+14.7%) |
| Mar 2020 | - | $1.33 M(+63.4%) |
| Dec 2019 | $815.00 K(-46.6%) | $815.00 K(-41.1%) |
| Sept 2019 | - | $1.38 M(+34.9%) |
| June 2019 | - | $1.02 M(-14.9%) |
| Mar 2019 | - | $1.20 M(-21.1%) |
| Dec 2018 | $1.53 M(+85.9%) | $1.53 M(+122.4%) |
| Sept 2018 | - | $686.00 K(+19.3%) |
| June 2018 | - | $575.00 K(+66.7%) |
| Mar 2018 | - | $345.00 K(-58.0%) |
| Dec 2017 | $821.00 K(-72.8%) | $821.00 K(+15.3%) |
| Sept 2017 | - | $712.00 K(-23.3%) |
| June 2017 | - | $928.00 K(-39.6%) |
| Mar 2017 | - | $1.54 M(-49.0%) |
| Dec 2016 | $3.02 M(-27.5%) | $3.02 M(-39.1%) |
| Sept 2016 | - | $4.95 M(+2.2%) |
| June 2016 | - | $4.85 M(+13.9%) |
| Mar 2016 | - | $4.26 M(+2.4%) |
| Dec 2015 | $4.16 M(-5.7%) | $4.16 M(+3.0%) |
| Sept 2015 | - | $4.04 M(-15.6%) |
| June 2015 | - | $4.79 M(+21.2%) |
| Mar 2015 | - | $3.95 M(-10.4%) |
| Dec 2014 | $4.41 M(-13.9%) | $4.41 M(+1.1%) |
| Sept 2014 | - | $4.36 M(+13.8%) |
| June 2014 | - | $3.83 M(-10.7%) |
| Mar 2014 | - | $4.29 M(-16.2%) |
| Dec 2013 | $5.12 M(+35.9%) | $5.12 M(-3.3%) |
| Sept 2013 | - | $5.29 M(+20.2%) |
| June 2013 | - | $4.41 M(-12.6%) |
| Mar 2013 | - | $5.04 M(+33.8%) |
| Dec 2012 | $3.77 M(-21.3%) | $3.77 M(-22.8%) |
| Sept 2012 | - | $4.88 M(-9.8%) |
| June 2012 | - | $5.41 M(+33.1%) |
| Mar 2012 | - | $4.06 M(-15.2%) |
| Dec 2011 | $4.79 M(+94.9%) | $4.79 M(+58.3%) |
| Sept 2011 | - | $3.03 M(+0.8%) |
| June 2011 | - | $3.00 M(-39.5%) |
| Mar 2011 | - | $4.96 M(+102.0%) |
| Dec 2010 | $2.46 M | $2.46 M(+42.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $1.73 M(+176.8%) |
| June 2010 | - | $625.00 K(-84.8%) |
| Mar 2010 | - | $4.12 M(+1128.7%) |
| Dec 2009 | $335.00 K(-39.9%) | $335.00 K(-38.4%) |
| Sept 2008 | - | $544.00 K(-7.0%) |
| June 2008 | - | $585.00 K(-46.7%) |
| Mar 2008 | - | $1.10 M(+97.1%) |
| Dec 2007 | $557.00 K(-0.7%) | $557.00 K(+25.7%) |
| Sept 2007 | - | $443.00 K(-21.6%) |
| June 2007 | - | $565.00 K(+44.9%) |
| Mar 2007 | - | $390.00 K(-30.5%) |
| Dec 2006 | $561.00 K(+8.3%) | $561.00 K(-17.7%) |
| Sept 2006 | - | $682.00 K(+176.1%) |
| June 2006 | - | $247.00 K(-62.6%) |
| Mar 2006 | - | $661.00 K(+27.6%) |
| Dec 2005 | $518.00 K(-24.8%) | $518.00 K(-23.7%) |
| Sept 2005 | - | $679.00 K(+15.1%) |
| June 2005 | - | $590.00 K(-18.4%) |
| Mar 2005 | - | $723.00 K(+4.9%) |
| Dec 2004 | $689.00 K(-54.2%) | $689.00 K(+1.6%) |
| Sept 2004 | - | $678.00 K(+6.9%) |
| June 2004 | - | $634.00 K(-19.0%) |
| Mar 2004 | - | $783.00 K(-48.0%) |
| Dec 2003 | $1.50 M(-20.8%) | $1.50 M(+101.7%) |
| Sept 2003 | - | $746.00 K(-52.8%) |
| June 2003 | - | $1.58 M(-16.8%) |
| Mar 2003 | - | $1.90 M(-0.2%) |
| Dec 2002 | $1.90 M(+112.6%) | $1.90 M(+61.8%) |
| Sept 2002 | - | $1.18 M(+38.4%) |
| June 2002 | - | $849.00 K(+55.8%) |
| Mar 2002 | - | $545.00 K(-39.0%) |
| Dec 2001 | $894.00 K(-31.4%) | $894.00 K(+51.5%) |
| Sept 2001 | - | $590.00 K(+6.9%) |
| June 2001 | - | $552.00 K(-47.3%) |
| Mar 2001 | - | $1.05 M(-19.6%) |
| Dec 2000 | $1.30 M(+63.0%) | $1.30 M(-2.3%) |
| Sept 2000 | - | $1.33 M(+375.1%) |
| June 2000 | - | $281.00 K(-73.0%) |
| Mar 2000 | - | $1.04 M(+30.3%) |
| Dec 1999 | $800.00 K(+100.0%) | $800.00 K(+300.0%) |
| Sept 1999 | - | $200.00 K(-75.0%) |
| June 1999 | - | $800.00 K(-11.1%) |
| Mar 1999 | - | $900.00 K(+125.0%) |
| Dec 1998 | $400.00 K(-50.0%) | $400.00 K(-33.3%) |
| Sept 1998 | - | $600.00 K(0.0%) |
| June 1998 | - | $600.00 K(-33.3%) |
| Mar 1998 | - | $900.00 K(+12.5%) |
| Dec 1997 | $800.00 K(+14.3%) | $800.00 K(-50.0%) |
| Sept 1997 | - | $1.60 M(+45.5%) |
| June 1997 | - | $1.10 M(+57.1%) |
| Mar 1997 | - | $700.00 K(0.0%) |
| Dec 1996 | $700.00 K(0.0%) | $700.00 K(0.0%) |
| Sept 1996 | - | $700.00 K(-12.5%) |
| June 1996 | - | $800.00 K(0.0%) |
| Mar 1996 | - | $800.00 K(+14.3%) |
| Dec 1995 | $700.00 K | $700.00 K |
FAQ
- What is Titan Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly accounts payable year-on-year change?
What is Titan Pharmaceuticals annual accounts payable?
The current annual accounts payable of TTNP is $348.00 K
What is the all time high annual accounts payable for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual accounts payable is $5.12 M
What is Titan Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of TTNP is $356.00 K
What is the all time high quarterly accounts payable for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly accounts payable is $5.41 M
What is Titan Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, TTNP quarterly accounts payable has changed by +$8000.00 (+2.30%)